Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ke Li
Guangzhou Medical University - State Key Laboratory of Respiratory Disease
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
67
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety, Tolerability, and Immunogenicity of a CpG/Alum Adjuvanted SARS-CoV-2 Recombinant Protein Vaccine (ZR202-CoV) in Healthy Adults: Preliminary Report of a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial
Number of pages: 21
Posted: 06 Mar 2023
Ke Li,
Zhongfang Wang
,
Peng He
,
Guang-Wei Feng
,
Qin-Ying Lan
,
Ling Ni
,
Ya-Zheng Yang
,
Chenfei Wang
,
Ting-Ting Cui
,
Lili Huang
,
Jin-Tao Gao
,
Zhiwei Jiang
,
Qing Yang
,
Bang-Wei Yu
,
Xi Han
,
Jing-Jing Chen
,
Shu-Yuan Yang
,
Lin Yuan
,
Ling-Yun Zhou
,
Zhen Huang
,
Zhiqiang Xie
,
Jincun Zhao
,
Zhong-Yu Hu
and
Ke Li
Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Government of the People's Republic of China - National Institutes for Food and Drug Control, Henan Provincial Center for Disease Control Prevention, Shanghai Zerun Biotechnology Co. LTD., Tsinghua University, Tsinghua University, National Institute for Food and Drug Control, Guangzhou Medical University - Guangzhou Institute of Respiratory Health, Henan Provincial Center for Disease Control Prevention, Xiangcheng County Center for Disease Control and Prevention, Beijing Key Tech Statistics Technology Co., Ltd., Shanghai Zerun Biotechnology Co. LTD., Shanghai Zerun Biotechnology Co. LTD., Shanghai Zerun Biotechnology Co. LTD., Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Walvax Biotechnology Co Ltd, Walvax Biotechnology Co Ltd, Shanghai Zerun Biotechnology Co. LTD., Walvax Biotechnology Co Ltd, Henan Provincial Center for Disease Control Prevention, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Government of the People's Republic of China - National Institutes for Food and Drug Control and Shanghai Zerun Biotechnology Co. LTD.
Downloads
67
(899,324)
View PDF
Download
Abstract:
COVID-19, SARS-CoV-2 vaccine, Safety, Immunogenicity, Placebo-controlled, Clinical trial
Feedback
